Guardant Health is engaging in strategic partnerships enabling global leaders in precision medicine.
Increasing global access to Guardant Health’s liquid biopsy platforms for greater patient identification for targeted therapy and clinical trials.
Know-how:
Bringing together Guardant Health’s
innovation with the expertise,
know-how, and service delivery of its partners
Quality:
State-of-the-art technology platform and
infrastructure supporting the delivery of a uniform,
high standard of care across all hospital settings
Contact Guardant Health
ctDNA, circulating tumor DNA; NGS, next-generation sequencing.
Volumes:
A high throughput liquid biopsy testing
facility established offering ctDNA
NGS testing across the country